Role of protein kinase C as a cellular mediator of ischemic preconditioning: A critical review

Cardiovascular Research

Volumn 40, Issue 1, 1998, Pages 9-22

  Simkhovich, Boris Z ^a   Przyklenk, Karin ^a   Kloner, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Ischemic preconditioning; Protein kinase C; Signal transduction

Indexed keywords

PROTEIN KINASE C;

ANIMAL TISSUE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME ASSAY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; DOGS; ENZYME ACTIVATION; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOENZYMES; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROTEIN KINASE C; RABBITS; RATS; SWINE;

EID: 0032190473     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00142-4     Document Type: Review

References (115)

1. [1] Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. [2] Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 1987;253:H1470-H1476.
3. [3] Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82:609-619.
4. 1 adenosine receptors in rabbit heart. Circulation 1991;84:350-356.
5. [5] Schott RJ, Rochmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-1142.
6. [6] Hale SL, Kloner RA. Effect of ischemic preconditioning on regional myocardial blood flow in the rabbit. Coron Artery Dis 1992;3:133-140.
7. [7] Li Y, Whittaker P, Kloner RA. The transient nature of the effect of ischemic preconditioning. Circulation 1992;123:346-353.
8. [8] Ytrehus K, Liu Y, Downey JD. Preconditioning protects ischemic rabbit heart by protein kinase C. Am J Physiol 1994;266:H1145-H1152.
9. [9] Liu Y, Ytrehus K, Downey JD. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26:661-668.
10. [10] Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-590.
11. [11] Mitchell MB, Meng X, Ao L, et al. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
12. + currents by protein kinase C and adenosine. Implications for ischemic preconditioning. Circ Res 1996;78:443-454.
13. [13] Ping P, Zhang J, Qui Y, et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 1997;81:404-414.
14. [14] Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction?. Biochem J 1993;291:329-343.
15. [15] Nishizuka Y Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496.
16. [16] Sugden PH, Bogoyevitch MA. Intracellular signaling through protein kinases in the heart. Cardiovasc Res 1995;30:478-492.
17. [17] Steinberg SF, Goldberg M, Rybin VO. Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 1995;27:141-153.
18. [18] Shubeita HE, Martinson EA, van Bilsen M, Chien KR, Brown JH. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1992;89:1305-1309.
19. [19] Decock JBJ, Gillespie-Brown J, Parker PJ, Sugden PH, Fuller SJ. Classical, novel and atypical isoforms of PKC stimulate ANF-and TRE/AP-1-regulated promoter activity in ventricular cardiomyocytes. FEBS Lett 1994;356:275-278.
20. 2+-ATPase gene expression in cultured neonatal rat heart cells. Am J Physiol 1996;271:H1031-H1039.
21. [21] Jideama NM, Noland TA, Raynor RL, et al. Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J Biol Chem 1996;271:23277-23283.
22. 2+ in isolated mammalian ventricular myocytes. J Physiol 1991;444:481-498.
23. 2+ in adult rat cardiac myocytes. Circ Res 1990;66:1143-1155.
24. [24] Yuan S, Sunahara FA, Sen AK. Tumor-promoting phorbol esters inhibit cardiac function and induce redistribution of protein kinase C in perfused beating rat heart. Circ Res 1987;61:372-378.
25. [25] Watson JE, Karmazyn M. Concentration-dependent effects of protein kinase C-activating and -nonactivating phorbol esters on myocardial contractility, coronary resistance, energy metabolism, prostacyclin synthesis, and ultrastructure in isolated rat hearts. Circ Res 1991;69:1114-1131.
26. [26] Hu K, Duan D, Li GR, Nattel S. Protein kinase C activates ATP-sensitive current in human and rabbit ventricular myocytes. Circ Res 1996;78:492-498.
27. + channels. A possible mechanistic link to ischemic preconditioning. Circ Res 1996;79:399-406.
28. [28] Bogoyevitch MA, Parker PJ, Sugden PH. Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-ε is a major isotype present, and it is activated by phorbol esters, epinephrine and endothelin. Circ Res 1993;72:757-767.
29. [29] Rybin VO, Steinberg SF. Protein kinase C isoform expression and regulation in the developing rat heart. Circ Res 1994;74:299-309.
30. [30] Ergbrüger W, Keffel J, Knocks M, et al. Protein kinase C isozymes in rat and human cardiovascular tissues. Br J Pharmacol 1997;120:177-186.
31. [31] Rouet-Benzineb P, Mohammadi K, Perennec J, et al. Protein kinase C isoform expression in normal and failing rabbit hearts. Circ Res 1996;79:153-161.
32. [32] Kariya K, Karns LR, Simpson PC. Expression of a constitutively activated mutant of the β-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the β-myosin heavy chain isogene. J Biol Chem 1991;226:10023-10026.
33. [33] Kemp BE, Parker MW, Hu S, Tiganis T, House C. Substrate and pseudosubstrate interactions with protein kinases: determinants of specificity. Trends Biochem Sci 1994;19:440-444.
34. [34] Takai Y, Kishimoto A, Kikkawa U, Mori T, Nishizuka Y. Unsaturated diacylglycerol as possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochem Biophys Res Comm 1979;91:1218-1224.
35. [35] Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 1980;255:2273-2276.
36. [36] Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982;257:7847-7851.
37. 2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature 1983;301:621-623.
38. 2+-induced and phorbol ester-stabilized membrane bindings of protein kinase C. J Biol Chem 1986;261:16438-16445.
39. [39] Mosior M, Epand RM. Characterization of the calcium-binding site that regulates association of protein kinase C with phospholipid bilayers. J Biol Chem 1994;269:13798-13805.
40. [40] Newton AC, Keranen LM. Phosphatidyl-L-serine is necessary for protein kinase C high-affinity interaction with diacylglycerol-containing membranes. Biochemistry 1994;33:6651-6658.
41. [41] Quest AF, Bardes ES, Bell RM. A phorbol ester binding domain of protein kinase C gamma. Deletion analysis of the Cys2 domain defines a minimal 43 amino acid peptide. J Biol Chem 1994;269:2961-2970.
42. [42] Quest AF, Bell RM. The regulatory region of protein kinase C gamma. Studies of phorbol ester binding to individual and combined functional segments expressed as glutathione-S-transferase fusion proteins indicate a complex mechanism of regulation by phospholipids, phorbol esters, and divalent cations. J Biol Chem 1994;269:20000-20012.
43. [43] Kazanietz MG, Wang S, Milne GW, et al. Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis. J Biol Chem 1995;270:21852-21859.
44. [44] Newton A. Protein kinase C: structure, function, and regulation. J Biol Chem 1995;270:28495-28499.
45. [45] Mochly-Rosen D, Klaner H, Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA 1991;88:3997-4000.
46. [46] Mochly-Rosen D. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 1995;268:247-251.
47. [47] Ron D, Chen CH, Caldwell J, et al. Cloning of an intracellular receptor for protein kinase C: a homologue of the beta subunit of G proteins. Proc Natl Acad Sci USA, 1994;91:839-843.
48. [48] Smith BL, Mochly-Rosen D. Inhibition of protein kinase C function by injection of intracellular receptors for enzyme. Biochem Biophys Res Comm 1992;188:1235-1240.
49. [49] Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model. Circulation 1995;92:1546-1557.
50. [50] O SJ, Cox MH, Crawford FA, Spinale FG. Protein kinase C activation before cardioplegic arrest: beneficial effects on myocyte contractility. J Thorac Cardiovasc Surg 1997;114:651-659.
51. [51] Chen CS, Poenie M. New fluorescent probes for protein kinase C. J Biol Chem 1993;268:15812-15822.
52. [52] Johnson JA, Gray MO, Karliner JS, Chen CH, Mochly-Rosen D. An improved permeabilization protocol for the introduction of peptides into cardiac myocytes. Application to protein kinase C research. Circ Res 1996;79:1086-1099.
53. [53] Johnson JA, Gray MO, Chen CH, Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 1996;271:24962-24966.
54. [54] Yang XM, Sato H, Downey JD, Cohen MV. Protection of ischemic preconditioning is dependent upon critical timing sequence of protein kinase C activation. J Mol Cell Cardiol 1997;29:991-999.
55. [55] Galiñanes M, Sutherland FJ, Brooks G, Hearse DJ. Temporal distribution of protein kinase C during ischemia and preconditioning: is cytosol to membrane translocation (activation) involved (Abstract). Circulation 1995;92(8(Suppl)):1-137.
56. [56] Simkhovich BZ, Przyklenk K, Hale SL, Patterson M, Kloner RA. Direct evidence that ischemic preconditioning does not cause protein kinase C translocation in rabbit heart. Cardiovasc Res 1996;32:1064-1070.
57. [57] Sandhu R, Diaz RJ, Mao GD, Wilson GJ. Ischemic preconditioning. Differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation 1997;96:984-995.
58. [58] Pongo E, Mubagawa K, Floeming W. Activity of protein kinase C in ischemic and stunned myocardium (Abstract). Eur Heart J 1997;18:77.
59. [59] Lasley RD, Noble MA, Konyn PJ, Mentzer RM. The protein kinase C inhibitor bisindolylmaleimide reduces myocardial interstitial purine accumulation and infarct size in the rabbit (Abstract). Circulation 1995;92:I-136.
60. 1-selective adenosine analogues protects the heart against infarction. Circulation 1992;85:659-665.
61. [61] Toombs CF, McGee DS, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992;86:986-994.
62. 1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits. Cardiovasc Res 1993;27:2140-2145.
63. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-585.
64. [64] Hale SL, Kloner RA. Protection of myocardium by transient, preischemic administration of phenylephrine in the rabbit. Coron Artery Dis 1994;5:605-610.
65. [65] Bankwala Z, Hale SL, Kloner RA. α-Adrenoreceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation 1994;90:1023-1028.
66. [66] Cohen MV, Downey JM. Ischemic preconditioning: can the protection be bottled. Lancet 1993;342:6.
67. [67] Blackshear PJ. The MARCKS family of cellular protein kinase C substrates. J Biol Chem 1993;268:1501-1504.
68. [68] Armstrong SC, Kao R, Gao W, et al. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effects of a protein phosphatase inhibitor; fostriecin. J Mol Cell Cardiol 1997;29:3009-3024.
69. [69] Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat heart. Am J Physiol 1995;268:H426-H431.
70. [70] Li Y, Kloner RA. Does inhibition of protein kinase C with H7 block the cardioprotective effects of ischemic preconditioning in the rat (Abstract). Circulation 1994;90(Suppl):I-371.
71. [71] Hidaka H, Inagaki M, Kawamoto S, Sassaki Y. Isoquinoline sulfonamides, novel potent inhibitors of cyclic nucleotide protein kinase and protein kinase C. Biochemistry 1984;23:5036-5041.
72. [72] Bugge E, Ytrehus K. Ischemic preconditioning is protein kinase C dependent but not through stimulation of a adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 1995;29:401-406.
73. [73] McCarty MF. Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion - the 'PKC syndrome'. Med Hypotheses 1996;46:191-221.
74. 1B-adrenoreceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 1995;92:2259-2265.
75. [75] Tosaki A, Maulik N, Engelman DT, Engelman RM, Das DK. The role of protein kinase C in ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol 1996;28:723-731.
76. [76] Chen W, Wetsel W, Steenbergen C, Murphy E. Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. J Mol Cell Cardiol 1996;28:871-880.
77. [77] Zhai X, Lawson CS, Cave AC, Hearse DJ. Preconditioning and post-ischemic contractile dysfunction: the role of impaired oxygen delivery vs extracellular metabolite accumulation. J Mol Cell Cardiol 1993;25:847-857.
78. [78] Cave AC, Silverman AS, Apstein CS. Ischemic preconditioning does not protect against contractile dysfunction in the presence of residual flow. Studies in the isolated, blood-perfused rat heart. Circulation 1997;96:3087-3093.
79. [79] Moolman JA, Genade S, Tromp E, Lochner A. No evidence for mediation of ischemic preconditioning by alpha 1-adrenergic signal transduction pathway or protein kinase C in the isolated rat heart. Cardiovasc Drugs Ther 1996;10:125-136.
80. [80] Wilson S, Song W, Karoly K, et al. Delayed cardioprotection is associated with the sub-cellular relocalisation of ventricular protein kinase Cε, but not p42/44MAPK. Mol Cell Biochem 1996;160-161:225-230.
81. [81] Brew EC, Mitchell MB, Rehring TF, et al. Role of bradykinin on cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol 1995;269:H1370-H1378.
82. ATP channels in the isolated rat heart. Cardiovasc Res 1996;32:920-929.
83. [83] Kitakaze M, Node K, Minamino T, et al. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidise. Circulation 1996;93:781-791.
84. 1-adrenoreceptor activation mediates the infarct size-limiting effect of ischemic preconditioning thorugh augmentation of 5′-nucleotidase activity. J Clin Invest 1994;93:2197-2205.
85. 1-receptor agonist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs. Cardiovasc Res 1996;32:830-838.
86. [86] Vogt AM, Htun P, Arras M, Podzuweit T, Schaper W. Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res Cardiol 1996;91:389-400.
87. [87] Vahlhaus C, Schulz R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by protein kinase C inhibitor staurosporine in swine. Circ Res 1996;79:407-414.
88. [88] Vahlhaus C, Scholz R, Post H, Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 1998;30:197-209.
89. [89] Higashi K, Ogawara H. Effects of isoflavone compounds on the activation of phospholipase C. Chem Pharm Bull 1992;40:157-160.
90. [90] Okajima F, Akbar M, Abdul Majid M, et al. Genistein, an inhibitor of protein tyrosine kinase, is also a competitive antagonist for P1-purinergic (adenosine) receptor in FRTL-5 thyroid cells. Biochem Biophys Res Comm 1994;203:1488-1495.
91. [91] Ji XD, Melman N, Jacobson KA. Interaction of flavonoids and other phytochemicals with adenosine receptors. J Med Chem 1996;39:781-788.
92. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995;77:1030-1035.
93. [93] Ikonomides JS, Tumiati LC, Weisel RD, Mickle DAG, Li RK. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischemia. Cardiovasc Res 1994;28:1285-1291.
94. [94] Ikonomides JS, Shirai T, Weisel RD, et al. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 1997;272:H1220-H1230.
95. 1-Receptor-independent activation of protein kinase C in acute myocardial ischemia. Circ Res 1992;70:1304-1312.
96. 1-adrenoreceptors. Am J Physiol 1997;273:H902-H908.
97. [97] Brooks G, Hearse DJ. Role of protein kinase C in ischemic preconditioning: player or spectator?. Circ Res 1996;79:627-630.
98. [98] Gray MO, Karliner JS, Mochly-Rosen D. A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 1997;272:30495-30951.
99. [99] Datta R, Kojima H, Yoshida K, Kufe D. Caspase-3-mediated cleavage of protein kinase C-θ in induction of apoptosis. J Biol Chem 1997;272:20317-20320.
100. 1 in the regulation of apoptosis. Leukemia Res 1996;20:319-326.
101. [101] Sawai H, Okazaki T, Takeda Y, et al. Ceramide-induced translocation of protein kinase C-δ and -ε to the cytosol. Implications in apoptosis. J Biol Chem 1997;272:2452-2458.
102. [102] Ghayur T, Hugunin M, Talanian RV, et al. Proteolytic activation of protein kinase C-δ by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 1996;184:2399-2404.
103. [103] Simkhovich BZ, Przyklenk K, Kloner RA. Temporal changes in the subcellular distribution of protein kinase C in rabbit heart during global ischemia. Basic Res Cardiol 1998;93:122-126.
104. [104] Graff JM, Rajan RR, Randal RR, Nairn AC, Blackshear PJ. Protein kinase C substrate and inhibitor characteristics of peptides derived from the myristoylated alanine-rich C kinase substrate (MARCKS) protein phosphorylation site domain. J Biol Chem 1991;266:14390-14398.
105. [105] Ammes B, Manjarrez-Hernandez HA, Howell SA, Learmonth M, Aitken A. Multisite phosphorylation of 80 kDa (MARCKS) protein kinase C substrate in C3H/10T1/2 fibroblasts. Quantitative analysis of individual sites by solid-phase microsequencing. FEBS Letters 1992;297:285-291.
106. [106] Koide H, Ogita K, Kikkawa U, Nishizuka Y. Isolation and characterization of the ∈ subspecies of protein kinase C from rat brain. Proc Natl Acad Sci USA 1992;89:1149-1153.
107. [107] Farrar YI, Vanaman TC, Slevin JT. A phosphatase resistant substrate for the assay of protein kinase C in crude tissue extracts. Biochem Biophys Res Comm 1991;180:694-701.
108. [108] Kochs G, Hummel R, Meyer D, et al. Activation and substrate specificity of the human protein kinase C α and ζ isoenzymes. J Biochem 1993;216:597-606.
109. [109] House C, Kemp BE. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science, 1987;238:1726-1728.
110. 2-and phospholipid-activated protein kinase C. J Biol Chem 1984;259:8743-8747.
111. [111] Chen SJ, Klann E, Gower MC, et al. Studies with synthetic peptide substrates derived from the neuronal protein neurogranin reveal structural determinants of potency and selectivity for protein kinase C. Biochemistry 1993;32:1032-1039.
112. [112] House C, Wettenhall RE, Kemp BE. The influence of basic residues on the substrate specificity of protein kinase C. J Biol Chem 1987;262:772-777.
113. [113] Promega Technical Bulletin (Part# TB132), Promega Corporation, Madison, WI.
114. [114] Cicirelli MF, Pelech SL, Krebs EG. Activation of multiple protein kinases during the burst in protein phosphorylation that precedes the first meiotic cell division in Xenopus oocytes. J Biol Chem 1988;263:2009-2019.
115. [115] Nakanishi H, Exton JH. Purification and characterization of the ζ isoform of protein kinase C from bovine kidney. J Biol Chem 1992;267:16347-16354.